ConductScience.org, home

Gene · 10020

Papers4,261

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

381 to 400 of 4,261

Download this page as JSON
TitleJournalYearPMIDFound bySource
Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes.Hum Genomics202337330543PubTator, text miningPubMed
Establishment and validation of an AI-aid method in the diagnosis of myocardial perfusion imaging.BMC Med Imaging202337328753PubTator, text miningPubMed
Riddles in the dark: Decoding the relationship between neuromelanin and neurodegeneration in locus coeruleus neurons.Neurosci Biobehav Rev202337327835PubTator, text miningPubMed
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.EBioMedicine202337327677PubTator, text miningPubMed
Systemic administration of the antisense oligonucleotide NS-089/NCNP-02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial.Neuropsychopharmacol Rep202337326950PubTator, text miningPubMed
Are probiotics beneficial for obese patients with major depressive disorder? Opinion for future implications and strategies.Front Nutr202337324742PubTator, text miningPubMed
Editorial: A year in review: discussions in obesity.Front Endocrinol (Lausanne)202337324255PubTator, text miningPubMed
Assessment of COVID-19 Impact on Commercial Sex Workers in India: A Formative Research by Media Scanning.Indian J Community Med202337323732PubTator, text miningPubMed
Plant-based biopharmaceutical engineering.Nat Rev Bioeng202337317690PubTator, text miningPubMed
Neurological update: non-motor symptoms in atypical parkinsonian syndromes.J Neurol202337316556PubTator, text miningPubMed
Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.BMC Psychiatry202337312091PubTator, text miningPubMed
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma.Hered Cancer Clin Pract202337308967PubTator, text miningPubMed
Mustard Gas Exposure Actuates SMAD2/3 Signaling to Promote Myofibroblast Generation in the Cornea.Cells202337296653PubTator, text miningPubMed
Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors.Front Immunol202337287989PubTator, text miningPubMed
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.Signal Transduct Target Ther202337286535PubTator, text miningPubMed
Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity.Sci Adv202337285422PubTator, text miningPubMed
Greater rate of return to play and re-injury following all-inside meniscal repair compared to the inside-out technique: a systematic review.Arch Orthop Trauma Surg202337284879PubTator, text miningPubMed
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance.Nat Cancer202337277530PubTator, text miningPubMed
A deep learning latent variable model to identify children with autism through motor abnormalities.Front Psychol202337275723PubTator, text miningPubMed
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine.
EPMA J202337275549PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10020/papers?page=20